[Improvement of coronary prognosis by reducing LDL-cholesterol].
Elevated LDL-cholesterol levels mean increased risk for coronary heart disease. In different studies the indication for decreasing high LDL-cholesterol in patients with coronary heart disease was proven. This is also the case with patients suffering from high LDL-cholesterol but not yet coronary heart disease. It is supposed that with longer duration of studies the total mortality between verum and placebo groups will also reach significance.
Wolfram
G
G
Medizinischen Poliklinik der Universität München.
D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D008078:Cholesterol, LDL / Q000097:blood*; D003324:Coronary Artery Disease / Q000097:blood / Q000517:prevention & control*; D006801:Humans; D008137:Longitudinal Studies; D012307:Risk Factors
D000924:Anticholesteremic Agents; D008078:Cholesterol, LDL
Verbesserung der Koronarprognose durch Senkung des LDL-Cholesterins.